Literature DB >> 17608261

Resolution of nonalcoholic steatohepatits after gastric bypass surgery.

Xiuli Liu1, Audrey J Lazenby, Ronald H Clements, Nirag Jhala, Gary A Abrams.   

Abstract

BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) has been increasingly recognized as a common chronic liver condition. Previous studies have been variable regarding the histological outcomes after rapid weight loss. The aim of this study was to characterize the histopathologic changes in NASH following laparoscopic Roux-en-Y Gastric Bypass surgery (LRYGBP).
METHODS: We retrospectively analyzed paired needle liver biopsies taken during and following LRYGBP in 39 patients according to the recent NIH-based NAFLD criteria.
RESULTS: The cohort included 33 females and 6 males (range 24-57 years). 23 patients (58.9%) had steatohepatitis, 12 with fatty liver (30.7%), and 4 were normal (10.2%). Follow-up needle liver biopsies were performed at a mean interval of 18 months (range 6-41 months). No significant differences in length or number of portal tracts between the paired biopsies were noted. The mean decrease in weight and BMI was 50.2 kg and 18.2 kg/m2, respectively. The initial prevalence of hepatic pathology: steatosis (89.7%), hepatocellular ballooning (58.9%), and centrilobular/perisinusoidal fibrosis (50%) improved significantly after LRYGBP: steatosis (2.9%), ballooning (0%), and centrilobular fibrosis (25%). Mitigation in the lobular inflammation score (2.23+/-0.63 vs 1.95+/-0.56, P=0.01) and stage of fibrosis (1.14+/-1.05 to 0.72+/-0.97, P=0.002) were also noted. However, no improvements were detected in portal tract inflammation and fibrosis.
CONCLUSIONS: Over a mean period of 18 months, histological improvements and resolution of NASH occurs after LRYGBP. Long-term studies are warranted to assess for potential changes in the portal regions or relapse of NASH that could result with weight regain or malnutrition.

Entities:  

Mesh:

Year:  2007        PMID: 17608261     DOI: 10.1007/s11695-007-9086-2

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  29 in total

1.  Histological findings in the liver before and after gastric bypass.

Authors:  Attila Csendes; Gladys Smok; Ana Maria Burgos
Journal:  Obes Surg       Date:  2006-05       Impact factor: 4.129

Review 2.  Etiopathogenesis of nonalcoholic steatohepatitis.

Authors:  S Chitturi; G C Farrell
Journal:  Semin Liver Dis       Date:  2001       Impact factor: 6.115

3.  Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease.

Authors:  Samuel Klein; Bettina Mittendorfer; J Christopher Eagon; Bruce Patterson; Lafaine Grant; Nikki Feirt; Ekihiro Seki; David Brenner; Kevin Korenblat; Jennifer McCrea
Journal:  Gastroenterology       Date:  2006-05       Impact factor: 22.682

4.  Non-alcoholic steatohepatitis: effect of Roux-en-Y gastric bypass surgery.

Authors:  Kevin B Barker; Nicole A Palekar; Steven P Bowers; Joel E Goldberg; Joseph P Pulcini; Stephen A Harrison
Journal:  Am J Gastroenterol       Date:  2006-02       Impact factor: 10.864

5.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.

Authors:  Giulio Marchesini; Elisabetta Bugianesi; Gabriele Forlani; Fernanda Cerrelli; Marco Lenzi; Rita Manini; Stefania Natale; Ester Vanni; Nicola Villanova; Nazario Melchionda; Mario Rizzetto
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

6.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.

Authors:  E M Brunt; C G Janney; A M Di Bisceglie; B A Neuschwander-Tetri; B R Bacon
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

7.  Roux-en-Y gastric bypass improves liver histology in patients with non-alcoholic fatty liver disease.

Authors:  Jeanne M Clark; Amir R A Alkhuraishi; Steven F Solga; Patricia Alli; Anna Mae Diehl; Thomas H Magnuson
Journal:  Obes Res       Date:  2005-07

8.  Searching for the best weight reduction operation.

Authors:  R D Rucker; E K Chan; J Horstmann; E P Chute; R L Varco; H Buchwald
Journal:  Surgery       Date:  1984-10       Impact factor: 3.982

9.  Roux-en-Y gastric bypass improves the nonalcoholic steatohepatitis (NASH) of morbid obesity.

Authors:  Soraya Rodrigues de Almeida; Paulo Roberto Savassi Rocha; Marcelo Dias Sanches; Virgínia Hora Rios Leite; Rogério Augusto Pinto da Silva; Marco Túlio Costa Diniz; Maria de Fátima Haueisen Sander Diniz; Alexandre Lages Savassi Rocha
Journal:  Obes Surg       Date:  2006-03       Impact factor: 4.129

Review 10.  Advances in the understanding and treatment of nonalcoholic fatty liver disease.

Authors:  Stephen A Harrison; Adrian M Di Bisceglie
Journal:  Drugs       Date:  2003       Impact factor: 9.546

View more
  35 in total

1.  Improvement of nonalcoholic fatty liver disease after bariatric surgery in morbidly obese Chinese patients.

Authors:  Chi-Ming Tai; Chih-Kun Huang; Jau-Chung Hwang; Hung Chiang; Chi-Yang Chang; Ching-Tai Lee; Ming-Lung Yu; Jaw-Town Lin
Journal:  Obes Surg       Date:  2012-07       Impact factor: 4.129

2.  Treatment options for nonalcoholic fatty liver disease.

Authors:  Brian Lam; Zobair M Younossi
Journal:  Therap Adv Gastroenterol       Date:  2010-03       Impact factor: 4.409

3.  Rapid Reversal of Liver Steatosis With Life Style Modification in Highly Motivated Liver Donors.

Authors:  Narendra S Choudhary; Neeraj Saraf; Sanjiv Saigal; Dheeraj Gautam; Lipika Lipi; Amit Rastogi; Sanjay Goja; Palat B Menon; Prashant Bhangui; Sumana K Ramchandra; Arvinder S Soin
Journal:  J Clin Exp Hepatol       Date:  2015-04-21

4.  Aerobic exercise training in the treatment of non-alcoholic fatty liver disease related fibrosis.

Authors:  Melissa A Linden; Ryan D Sheldon; Grace M Meers; Laura C Ortinau; E Matthew Morris; Frank W Booth; Jill A Kanaley; Victoria J Vieira-Potter; James R Sowers; Jamal A Ibdah; John P Thyfault; M Harold Laughlin; R Scott Rector
Journal:  J Physiol       Date:  2016-05-27       Impact factor: 5.182

Review 5.  Clinical review of nonalcoholic steatohepatitis in liver surgery and transplantation.

Authors:  Amit D Tevar; Calissia Clarke; Jiang Wang; Steven M Rudich; E Steve Woodle; Alex B Lentsch; Michael L Edwards
Journal:  J Am Coll Surg       Date:  2010-04       Impact factor: 6.113

6.  Effect of Roux-en-Y gastric bypass on nonalcoholic fatty liver disease evaluated through NAFLD fibrosis score: a prospective study.

Authors:  Everton Cazzo; Laísa Simakawa Jimenez; José Carlos Pareja; Elinton Adami Chaim
Journal:  Obes Surg       Date:  2015-06       Impact factor: 4.129

7.  [Indications and principles of metabolic surgery].

Authors:  R A Weiner
Journal:  Chirurg       Date:  2010-04       Impact factor: 0.955

Review 8.  Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: a Systematic Review of Liver Biochemistry and Histology.

Authors:  Guy Bower; Tania Toma; Leanne Harling; Long R Jiao; Evangelos Efthimiou; Ara Darzi; Thanos Athanasiou; Hutan Ashrafian
Journal:  Obes Surg       Date:  2015-12       Impact factor: 4.129

9.  Correlations of laparoscopy with histology and laboratory studies on liver diseases in bariatric patients.

Authors:  Chong-Chi Chiu; Wei-Jei Lee; Weu Wang; Yi-Chih Lee; Ming-Te Huang
Journal:  Obes Surg       Date:  2007-12-28       Impact factor: 4.129

Review 10.  Bariatric surgery for non-alcoholic steatohepatitis in obese patients.

Authors:  Norberto C Chavez-Tapia; Felix I Tellez-Avila; Tonatiuh Barrientos-Gutierrez; Nahum Mendez-Sanchez; Javier Lizardi-Cervera; Misael Uribe
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.